|
Educational Opportunities for Pathologists
The following postgraduate courses and lectures are
designed for practicing pathologists who encounter endometrial specimens in
their everyday practice. Unless specified otherwise,
they are directed
by the creator of this website (Dr. Mutter).
It is recommended that you contact the sponsoring
organization to confirm the final schedule and register in advance.
EIN (Endometrial Intraepithelial Neoplasia) and Ambiguous Premalignant
Endometrial Lesions October 16, 2008,
Baltimore, MD
This course, given at the
2008 annual
meeting of the American
Society of Clinical Pathologists (ASCP) is designed to review
criteria for diagnosis of neoplastic and metaplastic lesions of the
endometrium, with special emphasis on revised criteria for recognition of
precancers. A rationale for functional segregation into precancerous (EIN,
Endometrial Intraepithelial Neoplasia) and non-precancerous categories will
be presented, based upon new data from genetic, morphometric, and clinical
outcome studies. Special attention will be paid to resolution of
heterogenous categories of endometria formerly classified as "hyperplastic"
and “metaplastic.” This format will integrate didactic presentation with
discussion of representative patient examples in topical sessions. Clinical
material will be organized to illustrate the broad variety of presentations
of specific categories of disease, and be accompanied by discussions of
their resulting clinical management. This course is relevant to any
pathologist engaged in the interpretation of endometrial biopsies (trainees
and established pathologists).
Participation requires
registration with
the ASCP. Archived here at www.endometrium.org are
a
Sylabus and a color handout with
Unknown Cases.
Postgraduate Course in Gynecologic Pathology,
November 8-9, 2008 Ankara, Turkey.
One and a half day course in gynecologic pathology,
focusing upon precancerous lesions of the cervix, ovary, endometrium, and
breast. Course faculty includes staff from Brigham and Women's
Hospital (T.Ince, C.Crum, and G.Mutter), and Hacettepe University,
Ankara, Turkey. Registration required. Check back for further details.
Interpreting the Endometrial Biopsy; a "Hands On" Microscopic
Tutorial. November 15-16, 2008, Boston, MA
This tutorial, offered by the Division of Women's and Perinatal Pathology
at Brigham and Women's Hospital, and the Department of
Continuing Medical Education at Harvard
Medical School is designed to review diagnostic interpretive problems in
endometrial pathology, with an emphasis on unusual presentations of common
disorders. The course offers a unique format combining classroom teaching with
microscopic tutorial, and is limited to 39 participants. Microscopes will be
provided and each registrant will receive an illustrated course syllabus. This
course is relevant to any pathologist engaged in the interpretation of
endometrial biopsies, and clinicians managing patients with endometrial
disease. Check the Harvard Medical
School Office of Continuing Medical Education for details.
Chemoprevention of endometrial cancer.
Thursday, January 22, 2009, Garden Grove, CA
Dr. Mutter will speak about hormonal prevention of
endometrial cancer at the Gynecologic
Oncology Group Winter
Symposium entitled "Issues in Gvnecologic Cancer Prevention and
Survivorship." The winter symposium will
kick-off the Gynecologic Oncology Group (GOG) Semi-Annual Meeting in Garden
Grove, California at the Hyatt Regency Orange County. The symposium will
begin at 8:00 am and conclude around 3:00 pm. The morning sessions will
focus on Chemoprevention for Cervical, Endometrial and Ovarian Cancer, with
Dr. David Alberts, from the Arizona Cancer Center moderating. The
mid-morning session will focus on Lymphedema with
Dr. Joan Walker from the University of Oklahoma moderating. The afternoon
session will address Cancer Survivorship with Dr. Lari Wenzel from the
University of California-Irvine moderating. The
objectives of these sessions will be to familiarize and discuss new
developments in the prevention of cervical, ovarian and endometrial cancer,
as well as basic understanding and importance of quality of life
measurements and how they are used and new concepts.
Registration with the Gynecologic Oncology
Group is required.
|
